AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation
Status:
Terminated
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Randomized trial of low-dose amiodarone therapy versus catheter ablation (CA) in older
patients with persistent atrial fibrillation (AF).
Primary Objective: To compare amiodarone to catheter ablation in patients aged 50 to 80 years
with symptomatic AF for the composite outcome of hospitalization for cardiovascular cause or
emergency department visit for atrial arrhythmia
Phase:
Phase 4
Details
Lead Sponsor:
Guy Amit Population Health Research Institute
Collaborators:
Hamilton Health Sciences Corporation Population Health Research Institute